Literature DB >> 12678827

Application of pharmacophore models for the design and synthesis of new anticonvulsant drugs.

Barbara Malawska1, Angelo Scatturin.   

Abstract

The chemical diversity and various mechanisms of action of anticonvulsants make it difficult to identify a common pharmacophore. The present review outlines different pharmacophore models for anticonvulsant activity with emphasis on the development of new drugs. Some of them represent models for structurally different classes of compounds with similar mechanisms of action. Others represent pharmacophore models for similar chemical classes of compounds for which the mechanism of anticonvulsant action is not clear. A pharmacophore model for sodium channel blocking compounds, anticonvulsants with the phthalimide pharmacophore, a model for anticonvulsant semicarbazones, and a model for GABA uptake inhibitors are presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678827     DOI: 10.2174/1389557033488088

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  3 in total

1.  Synthesis and evaluation of 4-substituted semicarbazones of levulinic acid for anticonvulsant activity.

Authors:  Navneet Aggarwal; Pradeep Mishra
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

2.  Preliminary anticonvulsant and toxicity screening of substituted benzylidenehydrazinyl-N-(6-substituted benzo[d]thiazol-2-yl)propanamides.

Authors:  Ruhi Ali; Nadeem Siddiqui
Journal:  ScientificWorldJournal       Date:  2014-12-11

3.  In silico Screening and Evaluation of the Anticonvulsant Activity of Docosahexaenoic Acid-Like Molecules in Experimental Models of Seizures.

Authors:  Ali Gharibi Loron; Soroush Sardari; Jamshid Narenjkar; Mohammad Sayyah
Journal:  Iran Biomed J       Date:  2016-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.